Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial of BT-11 in Mild to Moderate Ulcerative Colitis

Press/Media

Period	20 Aug 2019

Media coverage

Title	Landos Biopharma Announces First Patient Dosed in Global Phase 2 Clinical Trial of BT-11 in Mild to Moderate Ulcerative Colitis
Media name/outlet	PipelineReview
Country/Territory	Spain
Date	20/08/19
URL	https://pipelinereview.com/index.php/2019082072045/Small-Molecules/Landos-Biopharma-Announces-First-Patient-Dosed-in-Global-Phase-2-Clinical-Trial-of-BT-11-in-Mild-to-Moderate-Ulcerative-Colitis.html
Persons	Jean-Frédéric Colombel